Cite
HARVARD Citation
Español Rego, M. et al. (n.d.). 611TiPAVEVAC: A phase I-II trial with avelumab plus autologous dendritic cell (ADC) vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer (mCRC) patients (GEMCAD 16-02). Annals of oncology. p. . [Online].